Salt Lake City, UT, Aug. 18, 2017 -- SALT LAKE CITY, August 21, 2017 /PRNewswire/--ARUP Laboratories and IllumiCare have announced a strategic collaboration to provide clinicians with content and decision support.
|
|||||
In an era of rising patient deductibles and health insurance premiums, it is ever more important to spend healthcare dollars efficiently. Physicians are being asked to provide “value-based care,” yet they are not routinely told what things cost.
“ARUP has long been an advocate of empowering clinicians with current testing knowledge and providing unparalleled guidance through ARUP’s utilization management services,” says Andrew Fletcher, MD, the ARUP medical director of Consultative Services. “We are excited to share the research and expertise of our 90+ medical directors.”
IllumiCare’s Smart Ribbon is a non-intrusive ribbon of information that hovers over or embeds within the electronic medical record and provides real-time visibility of the cumulative risk and financial impact of tests and medications being ordered during the course of care. Studies show that displaying cost and risk of patient harm at the point of care causes physicians to provide safer and more efficient care.
“This partnership allows us to bring the expertise and best practice recommendations of a leading national reference laboratory to physicians at the point of care,” says G.T. LaBorde, CEO of IllumiCare. “Clinicians are being asked to remove waste and provide better care at a lower cost. The Smart Ribbon, with ARUP, provides valuable content for informed decision making, helping to reduce clinical and cost variation during the treatment of care.”
IllumiCare and ARUP together recognize that behind each lab test is a patient that may experience discomfort and a risk of harm. This collaboration seeks to ensure that patients receive the right test at the right time.
Media Contacts:
Cyndee Holden, (801) 583-2787, ext. 3318, [email protected]
G.T. LaBorde, (205) 719-8595, [email protected]
About ARUP Laboratories
Founded in 1984, ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation's top university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®. ARUP is ISO 15189 CAP accredited.
About IllumiCare
Founded in 2014, IllumiCare displays clinical, financial, and patient safety data in a non-intrusive, EMR agnostic “ribbon.” The data displayed can be customized by facility, care setting, user type, and patient type. Cost transparency, predictive analytics, population health and other analytics are powerful tools. They are most effective when provided to your clinicians in real-time, at the point of care.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/86603cd9-a1e7-4efb-8ae8-27579dc70b74
Catherine Arnold ARUP Laboratories (801) 583-2787, ext. 3635 [email protected]


Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 



